.png)
Sun Pharmaceutical Industries has entered into an agreement to acquire Mumbai-based Innovcare Lifesciences Private Limited for approximately Rs 271.2 crore.
According to a regulatory filing, the drugmaker will acquire Innovcare’s entire shareholding for cash consideration, taking ownership of 100% of the company’s outstanding shares. The transaction is slated to be completed on or before July 31, 2026.
Innovcare is engaged in the marketing, distribution and sale of pharmaceutical, nutraceutical and cosmeceutical products across India. The company reported revenue from operations of Rs 94.06 crore in FY26, compared to Rs 86.09 crore in FY25 and Rs 80.93 crore in FY24.
Sun Pharma said the acquisition aligns with its efforts to expand and strengthen its product portfolio. The company also clarified that the deal is not a related-party transaction and that neither its promoters nor promoter group entities have any stake or interest in Innovcare.
